Cargando…

Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China

To compare the difference between University of Wisconsin (UW) solution and histidine-tryptophan-ketoglutarate (HTK) solution in adult living donor liver transplantation (LDLT). This study included LDLT patients at the Liver Transplantation Center of West China Hospital of Sichuan University from No...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xi, Zhu, Yun-Feng, Lv, Tao, Zheng, Jin-Li, Li, Yong-kun, Zhang, Bo-Han, Jiang, Li, Yang, Jia-yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748334/
https://www.ncbi.nlm.nih.gov/pubmed/33371088
http://dx.doi.org/10.1097/MD.0000000000023584
_version_ 1783625092312334336
author Xu, Xi
Zhu, Yun-Feng
Lv, Tao
Zheng, Jin-Li
Li, Yong-kun
Zhang, Bo-Han
Jiang, Li
Yang, Jia-yin
author_facet Xu, Xi
Zhu, Yun-Feng
Lv, Tao
Zheng, Jin-Li
Li, Yong-kun
Zhang, Bo-Han
Jiang, Li
Yang, Jia-yin
author_sort Xu, Xi
collection PubMed
description To compare the difference between University of Wisconsin (UW) solution and histidine-tryptophan-ketoglutarate (HTK) solution in adult living donor liver transplantation (LDLT). This study included LDLT patients at the Liver Transplantation Center of West China Hospital of Sichuan University from November 2001 to June 2018. These patients were classified into 2 groups depending on the use of the different preservation solutions, and the confounding factors between the 2 groups were eliminated by propensity score matching. Finally, the incidence of complications; serum examination at postoperative days 1, 3, 5, 7, 14, 21, and 30; and the overall survival rate of the 2 groups were compared to observe whether there were any differences between the 2 preservation solutions. Of the 298 patients we screened, 170 were treated with UW solution and 128 with HTK solution. After propensity score matching, 106 pairs of patients were selected. In the comparison of the 2 groups, the length of intensive care unit stay in the UW group was significantly longer than that in the HTK group (P = .022), but there was no difference in the total length of hospital stay between the 2 groups (P = .277). No statistically significant difference was observed in the 2 groups in terms of the incidence of complications or postoperative examinations. However, the incidence of early allograft dysfunction in the HTK group was slightly lower than that in the UW group (HTK: UW = 14.1%: 20.7%), although the difference was not statistically significant. In terms of the overall survival rate, the 1, 3, and 5-year survival rates of the HTK group were 85.5%, 70.2%, and 65.1%, respectively, while the 1, 3, and 5-year survival rates of the UW group were 83.1%, 67.2%, and 59.8%, respectively, and there was no significant difference between the 2 groups. In conclusion, our study shows that UW solution and HTK solution are equivalent in perioperative safety, the recovery of transplanted liver function, the occurrence of postoperative complications and overall survival and can be safely and effectively applied in adult LDLT. If economic factors are taken into account, HTK can save costs to a certain extent.
format Online
Article
Text
id pubmed-7748334
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77483342020-12-21 Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China Xu, Xi Zhu, Yun-Feng Lv, Tao Zheng, Jin-Li Li, Yong-kun Zhang, Bo-Han Jiang, Li Yang, Jia-yin Medicine (Baltimore) 4500 To compare the difference between University of Wisconsin (UW) solution and histidine-tryptophan-ketoglutarate (HTK) solution in adult living donor liver transplantation (LDLT). This study included LDLT patients at the Liver Transplantation Center of West China Hospital of Sichuan University from November 2001 to June 2018. These patients were classified into 2 groups depending on the use of the different preservation solutions, and the confounding factors between the 2 groups were eliminated by propensity score matching. Finally, the incidence of complications; serum examination at postoperative days 1, 3, 5, 7, 14, 21, and 30; and the overall survival rate of the 2 groups were compared to observe whether there were any differences between the 2 preservation solutions. Of the 298 patients we screened, 170 were treated with UW solution and 128 with HTK solution. After propensity score matching, 106 pairs of patients were selected. In the comparison of the 2 groups, the length of intensive care unit stay in the UW group was significantly longer than that in the HTK group (P = .022), but there was no difference in the total length of hospital stay between the 2 groups (P = .277). No statistically significant difference was observed in the 2 groups in terms of the incidence of complications or postoperative examinations. However, the incidence of early allograft dysfunction in the HTK group was slightly lower than that in the UW group (HTK: UW = 14.1%: 20.7%), although the difference was not statistically significant. In terms of the overall survival rate, the 1, 3, and 5-year survival rates of the HTK group were 85.5%, 70.2%, and 65.1%, respectively, while the 1, 3, and 5-year survival rates of the UW group were 83.1%, 67.2%, and 59.8%, respectively, and there was no significant difference between the 2 groups. In conclusion, our study shows that UW solution and HTK solution are equivalent in perioperative safety, the recovery of transplanted liver function, the occurrence of postoperative complications and overall survival and can be safely and effectively applied in adult LDLT. If economic factors are taken into account, HTK can save costs to a certain extent. Lippincott Williams & Wilkins 2020-12-18 /pmc/articles/PMC7748334/ /pubmed/33371088 http://dx.doi.org/10.1097/MD.0000000000023584 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 4500
Xu, Xi
Zhu, Yun-Feng
Lv, Tao
Zheng, Jin-Li
Li, Yong-kun
Zhang, Bo-Han
Jiang, Li
Yang, Jia-yin
Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China
title Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China
title_full Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China
title_fullStr Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China
title_full_unstemmed Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China
title_short Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: A propensity score matching analysis from mainland China
title_sort histidine-tryptophan-ketoglutarate solution versus university of wisconsin solution in adult-to-adult living donor liver transplantation: a propensity score matching analysis from mainland china
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748334/
https://www.ncbi.nlm.nih.gov/pubmed/33371088
http://dx.doi.org/10.1097/MD.0000000000023584
work_keys_str_mv AT xuxi histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina
AT zhuyunfeng histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina
AT lvtao histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina
AT zhengjinli histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina
AT liyongkun histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina
AT zhangbohan histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina
AT jiangli histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina
AT yangjiayin histidinetryptophanketoglutaratesolutionversusuniversityofwisconsinsolutioninadulttoadultlivingdonorlivertransplantationapropensityscorematchinganalysisfrommainlandchina